ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?

被引：0

作者：

Hsu, Jingmei ^{[1
]}

Kumar, Anita J. ^{[1
]}

Carroll, Martin P. ^{[1
]}

Frey, Noelle V. ^{[1
]}

Shah, Nirav N. ^{[1
,2
]}

Jianhua, Zhao ^{[3
]}

Hexner, Elizabeth O. ^{[1
]}

Loren, Alison W. ^{[1
]}

Mangan, James K. ^{[1
]}

Perl, Alexander E. ^{[1
]}

Porter, David ^{[1
]}

Morrissette, Jennifer ^{[3
]}

Luger, Selina M. ^{[1
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Hosp Univ Penn, Philadelphia, PA 19104 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] ASXL1/2 mutations and myeloid malignancies
Medina, Edward A.
Delma, Caroline R.
Yang, Feng-Chun
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[22] Mutations of ASXL1 gene in myeloproliferative neoplasms
N Carbuccia
A Murati
V Trouplin
M Brecqueville
J Adélaïde
J Rey
W Vainchenker
O A Bernard
M Chaffanet
N Vey
D Birnbaum
M J Mozziconacci
Leukemia, 2009, 23 : 2183 - 2186
[23] Mutations of ASXL1 gene in myeloproliferative neoplasms
Carbuccia, N.
Murati, A.
Trouplin, V.
Brecqueville, M.
Adelaide, J.
Rey, J.
Vainchenker, W.
Bernard, O. A.
Chaffanet, M.
Vey, N.
Birnbaum, D.
Mozziconacci, M. J.
LEUKEMIA, 2009, 23 (11) : 2183 - 2186
[24] AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients
Alpermann, Tamara
Haferlach, Claudia
Eder, Christiane
Nadarajah, Niroshan
Meggendorfer, Manja
Kern, Wolfgang
Haferlach, Torsten
Schnittger, Susanne
LEUKEMIA RESEARCH, 2015, 39 (03) : 265 - 272
[25] Clinical implication and prognostic significance of FLT3-ITD and ASXL1 mutations in Egyptian AML patients: A single-center study
Ebian, Huda F.
Elshorbagy, Sherin
Mohamed, Haitham
Embaby, Ahmad
Khamis, Tarek
Sameh, Reham
Sabbah, Norhan A.
Hussein, Samia
CANCER BIOMARKERS, 2021, 32 (03) : 379 - 389
[26] Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations
Sugimoto, Yuka
Muramatsu, Hideki
Makishima, Hideki
Prince, Courtney
Jankowska, Anna M.
Yoshida, Nao
Xu, Yinyan
Nishio, Nobuhiro
Hama, Asahito
Yagasaki, Hiroshi
Takahashi, Yoshiyuki
Kato, Koji
Manabe, Atsushi
Kojima, Seiji
Maciejewski, Jaroslaw P.
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 83 - 87
[27] EZH2 MUTATION INTERACTS CLOSELY WITH ASXL1 AND AML1/RUNX1 MUTATIONS IN PATIENTS WITH de novo MYELODYSPLASTIC SYNDROME
Chuang, M. K.
Hou, H. A.
Kuo, Y. Y.
Chou, W. C.
Lee, M. C.
Chen, C. Y.
Lai, Y. J.
Tseng, M. H.
Huang, C. F.
Chiang, Y. C.
Lee, F. Y.
Liu, M. C.
Liu, C. W.
Tang, J. L.
Yao, M.
Huang, S. Y.
Ko, B. S.
Hsu, S. C.
Wu, S. J.
Lin, C. T.
Li, C. C.
Tsay, W.
Chen, Y. C.
Tien, H. F.
HAEMATOLOGICA, 2012, 97 : 131 - 132
[28] Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
Anand Balasubramani
Antti Larjo
Jed A. Bassein
Xing Chang
Ryan B. Hastie
Susan M. Togher
Harri Lähdesmäki
Anjana Rao
Nature Communications, 6
[29] ASXL1 mutations in Chinese patients with essential thrombocythemia
Nie, Yan-Bo
Sun, Meng
He, Colin K.
Ju, Man-Kai
Zhou, Fu-Ling
Wu, San-Yun
Zhou, Yi
Liu, Li
Shen, Hui
Huang, Ting-Ting
Liu, Pan
Xu, Ying
Shao, Liang
Zuo, Xue-Lan
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (05) : 4149 - 4156
[30] Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia
Braun, Theodore
Foley, Amy
Druker, Brian J.
Maxson, Julia E.
BLOOD, 2018, 132

← 1 2 3 4 5 →